MHC TYPING OF MACAQUES USED IN AIDS RESEARCH
用于艾滋病研究的猕猴 MHC 分型
基本信息
- 批准号:7958756
- 负责人:
- 金额:$ 19.66万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-05-01 至 2010-04-30
- 项目状态:已结题
- 来源:
- 关键词:Acquired Immunodeficiency SyndromeAllelesAmericanAnimal ModelBindingCell LineChinese PeopleCommunitiesComputer Retrieval of Information on Scientific Projects DatabaseEuropeanFundingGrantHIV vaccineImmunogeneticsIndividualInstitutionLaboratoriesMHC Class I GenesMacacaMacaca mulattaMolecularPathogenesisPeptidesPrimatesPrincipal InvestigatorResearchResearch PersonnelResourcesSIVServicesSourceSpecificityTechniquesTechnologyTestingTrainingUnited States National Institutes of HealthWisconsinWorksimian human immunodeficiency virusvaccine developmentvirology
项目摘要
This subproject is one of many research subprojects utilizing the
resources provided by a Center grant funded by NIH/NCRR. The subproject and
investigator (PI) may have received primary funding from another NIH source,
and thus could be represented in other CRISP entries. The institution listed is
for the Center, which is not necessarily the institution for the investigator.
Objective: To offer MHC typing of the MHC class I and II loci for investigators working with macaques (Indian rhesus, Chinese rhesus, and Cynomolgus). To adapt technologies for HLA typing to molecular typing of macaque (Indian rhesus, Chinese rhesus, and Cynomolgus) MHC class I and II.
The increased utility of various species of macaques as animal models in both HIV vaccine development and pathogenesis studies necessitates the continuation of reference MHC typing laboratories for these species. We plan to continue to offer services to both the North American and European scientific communities for MHC typing of macaques. Initially, this will include PCR-SSP tests for alleles encoding MHC class I and II molecules that bind peptides derived from SIV and SHIV. We are developing additional molecular techniques for analysis of the Indian rhesus and Chinese rhesus and Cynomolgus macaque MHC class I and class II alleles. Additionally, we offer training for individual laboratories that wish to set up MHC typing. Finally, we are developing a panel of well-characterized cell lines that will be invaluable for the analysis of the MHC in the macaque. Since 2002 to the present, we have performed over 120,000 typings for over 130 investigators at 50 institutions. In 2008, we have conducted 23,500 typings at the request of 32 principal investigators from 15 different institutions. In addition, we have developed and are preparing to offer expanded typing services during 2009, which include typing specificities for a total of ~35 Class I and ~20 Class II allele specificities of the Indian rhesus macaque. This research used WNPRC Immunogenetics & Virology Services.
这个子项目是众多研究子项目之一
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
David I Watkins其他文献
HIV pathogenesis: the first cut is the deepest
艾滋病病毒发病机制:初次感染影响最为深远
- DOI:
10.1038/ni0505-430 - 发表时间:
2005-05-01 - 期刊:
- 影响因子:27.600
- 作者:
Louis J Picker;David I Watkins - 通讯作者:
David I Watkins
David I Watkins的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('David I Watkins', 18)}}的其他基金
Learning from the Ebola success: Can a mAb also save lives after yellow fever infection?
借鉴埃博拉病毒的成功经验:单克隆抗体也能拯救黄热病感染后的生命吗?
- 批准号:
10422995 - 财政年份:2021
- 资助金额:
$ 19.66万 - 项目类别:
Learning from the Ebola success: Can a mAb also save lives after yellow fever infection?
借鉴埃博拉病毒的成功经验:单克隆抗体也能拯救黄热病感染后的生命吗?
- 批准号:
10669613 - 财政年份:2021
- 资助金额:
$ 19.66万 - 项目类别:
Learning from the Ebola success: Can a mAb also save lives after yellow fever infection?
借鉴埃博拉病毒的成功经验:单克隆抗体也能拯救黄热病感染后的生命吗?
- 批准号:
10463875 - 财政年份:2021
- 资助金额:
$ 19.66万 - 项目类别:
Can vaccine-induced CD8 T cells prevent chronic phase AIDS virus replication?
疫苗诱导的 CD8 T 细胞能否阻止慢性期艾滋病病毒复制?
- 批准号:
8787712 - 财政年份:2014
- 资助金额:
$ 19.66万 - 项目类别:
Can vaccine-induced CD8 T cells prevent chronic phase AIDS virus replication?
疫苗诱导的 CD8 T 细胞能否阻止慢性期艾滋病病毒复制?
- 批准号:
8976140 - 财政年份:2014
- 资助金额:
$ 19.66万 - 项目类别:
Yellow Fever, rDNA (EP+IL-12) and rAd35 as Vectors for AIDS Vaccine Development
黄热病、rDNA (EP IL-12) 和 rAd35 作为艾滋病疫苗开发的载体
- 批准号:
8497605 - 财政年份:2012
- 资助金额:
$ 19.66万 - 项目类别:
Yellow Fever, rDNA (EP+IL-12) and rAd35 as Vectors for AIDS Vaccine Development
黄热病、rDNA (EP IL-12) 和 rAd35 作为艾滋病疫苗开发的载体
- 批准号:
8688135 - 财政年份:2012
- 资助金额:
$ 19.66万 - 项目类别:
Yellow Fever, rDNA (EP+IL-12) and rAd35 as Vectors for AIDS Vaccine Development
黄热病、rDNA (EP IL-12) 和 rAd35 作为艾滋病疫苗开发的载体
- 批准号:
8301117 - 财政年份:2012
- 资助金额:
$ 19.66万 - 项目类别:
Yellow Fever, rDNA (EP+IL-12) and rAd35 as Vectors for AIDS Vaccine Development
黄热病、rDNA (EP IL-12) 和 rAd35 作为艾滋病疫苗开发的载体
- 批准号:
8874851 - 财政年份:2012
- 资助金额:
$ 19.66万 - 项目类别:
相似海外基金
Linkage of HIV amino acid variants to protective host alleles at CHD1L and HLA class I loci in an African population
非洲人群中 HIV 氨基酸变异与 CHD1L 和 HLA I 类基因座的保护性宿主等位基因的关联
- 批准号:
502556 - 财政年份:2024
- 资助金额:
$ 19.66万 - 项目类别:
Olfactory Epithelium Responses to Human APOE Alleles
嗅觉上皮对人类 APOE 等位基因的反应
- 批准号:
10659303 - 财政年份:2023
- 资助金额:
$ 19.66万 - 项目类别:
Deeply analyzing MHC class I-restricted peptide presentation mechanistics across alleles, pathways, and disease coupled with TCR discovery/characterization
深入分析跨等位基因、通路和疾病的 MHC I 类限制性肽呈递机制以及 TCR 发现/表征
- 批准号:
10674405 - 财政年份:2023
- 资助金额:
$ 19.66万 - 项目类别:
An off-the-shelf tumor cell vaccine with HLA-matching alleles for the personalized treatment of advanced solid tumors
具有 HLA 匹配等位基因的现成肿瘤细胞疫苗,用于晚期实体瘤的个性化治疗
- 批准号:
10758772 - 财政年份:2023
- 资助金额:
$ 19.66万 - 项目类别:
Identifying genetic variants that modify the effect size of ApoE alleles on late-onset Alzheimer's disease risk
识别改变 ApoE 等位基因对迟发性阿尔茨海默病风险影响大小的遗传变异
- 批准号:
10676499 - 财政年份:2023
- 资助金额:
$ 19.66万 - 项目类别:
New statistical approaches to mapping the functional impact of HLA alleles in multimodal complex disease datasets
绘制多模式复杂疾病数据集中 HLA 等位基因功能影响的新统计方法
- 批准号:
2748611 - 财政年份:2022
- 资助金额:
$ 19.66万 - 项目类别:
Studentship
Recessive lethal alleles linked to seed abortion and their effect on fruit development in blueberries
与种子败育相关的隐性致死等位基因及其对蓝莓果实发育的影响
- 批准号:
22K05630 - 财政年份:2022
- 资助金额:
$ 19.66万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Genome and epigenome editing of induced pluripotent stem cells for investigating osteoarthritis risk alleles
诱导多能干细胞的基因组和表观基因组编辑用于研究骨关节炎风险等位基因
- 批准号:
10532032 - 财政年份:2022
- 资助金额:
$ 19.66万 - 项目类别:
Investigating the Effect of APOE Alleles on Neuro-Immunity of Human Brain Borders in Normal Aging and Alzheimer's Disease Using Single-Cell Multi-Omics and In Vitro Organoids
使用单细胞多组学和体外类器官研究 APOE 等位基因对正常衰老和阿尔茨海默病中人脑边界神经免疫的影响
- 批准号:
10525070 - 财政年份:2022
- 资助金额:
$ 19.66万 - 项目类别:
Leveraging the Evolutionary History to Improve Identification of Trait-Associated Alleles and Risk Stratification Models in Native Hawaiians
利用进化历史来改进夏威夷原住民性状相关等位基因的识别和风险分层模型
- 批准号:
10689017 - 财政年份:2022
- 资助金额:
$ 19.66万 - 项目类别: